Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000589

Drug Information
NameCaptopril    
Synonyms1-[(2S)-2-methyl-3-sulfanylpropanoyl]-L-proline; HMS500K10; BPBio1_000063; 3-Mercapto-2-methylpropionyl-proline; MLS000069484; 1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline; HSDB 6527; SQ-14225; captopril; L-Proline, 1-(3-mercapto-2-methyl-1-oxopropyl)-, (S)-; Apopril (TN); IDI1_000208; KBioSS_001168; BSPBio_000057; D00251; Spectrum3_001388; C4042_SIGMA; (S)-1-(3-Mercapto-2-methyl-1-oxo-propyl)-L-proline; NCGC00023654-09; SQ-14534; NCGC00023654-07; KBio2_001168; Asisten; Aceplus; (2S)-1-(3-Mercapto-2-methylpropionyl)-L-proline; 1-(D-3-Mercapto-2-methyl-1-oxopropyl)-L-proline (S,S); CHEBI:3380; 1j37; Capoten; C9H15NO3S; (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline; SMP1_000056; Acepress; KBioGR_001321; NCGC00023654-06; KBio1_000208; AC-12047; Prestwick3_000019; Lopril; SPBio_001022; CID44093; Garranil; Captopryl; CPD0-2067; BIM-0050290.0001; X8Z; Tensobon; SQ 14,225; Tensiomin; D-3-Mercapto-2-methylpropionylproline; EU-0100302; MLS001076488; KBio3_002196; Cesplon; FT-0082749; BB_NC-2104; Captoprilum [INN-Latin]; 1-((2S)-3-Mercapto-2-methylpropionyl)-L-proline; Capoten (TN); BSPBio_002976; DivK1c_000208; D-3-Mercapto-2-methylpropanoyl-L-proline; Acediur; 1-Pyrrolidinecarboxylic acid, 1-(D-3-mercapto-2-methyl-1-propionyl)-, L-(S,S)-; KBio2_006304; SQ 14225; Isopresol; MCO; KBio2_003736; Captopril (JP15/USP/INN); C 4042; Lopirin [Switzerland]; UNII-9G64RSX1XD; Hypertil; NCGC00023654-10; SPECTRUM1500682; NCGC00023654-04; CHEMBL1560; UPCMLD-DP003; Alopresin; NCGC00023654-05; SAM002564201; Apopril; Acepril; L-Captopril; BRD-K54529596-001-04-0; AC1Q5R48; Tensoprel; N-[(S)-3-Mercapto-2-methylpropionyl]-L-proline; Captopril [USAN:INN:BAN:JAN]; HMS1921C12; HMS2092I12; L-Proline, 1-((2S)-3-mercapto-2-methyl-1-oxopropyl)-; Hipertil; (2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid; DB01197; Tenosbon; C8856_SIAL; SQ-14,534; C4042_SIAL; MolPort-001-794-639; NCGC00015235-02; NCGC00023654-03; Lopac0_000302; SQ-14,225; STK802012; AC1Q29GZ; Captril; Dilabar; ST079562; NCGC00023654-08; Captoprilum; Prestwick_103; [2S]-1-[3-Mercapto-2-methylpropionyl]-L-proline; Lopirin; Spectrum_000688; Captoril; Spectrum2_001211; LS-137465; Garranil (discontinued); EINECS 263-607-1; 62571-86-2; UPCMLD-DP003:001; Spectrum4_000811; CPD000059061; AC1L2B4L; CHEMBL82; SMR000059061; Spectrum5_001587; D-2-Methyl-3-mercaptopropanoyl-L-proline; HMS2089P19; SA 333; NCGC00015235-01; Lopac-C-4042; NINDS_000208; Captolane    
Trade NameCapoten    
CompanyBristol-Myers Squibb    
IndicationHypertensionApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntihypertensive Agents    
CAS NumberCAS 62571-86-2
FormularC9H15NO3S    
PubChem Compound IDCID 44093.    
PubChem Substance IDSID 184356.    
ChEBI3380;    
SuperDrug ATC IDC09AA01;    
SuperDrug CAS ID062571862;    
TargetAngiotensin-converting enzymeInhibitor[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 074322 To Reference
Ref 2Using ACE inhibitors appropriately. Am Fam Physician. 2002 Aug 1;66(3):461-8. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543